ChinaAniH   

ChinaAniH

Up trend is still intact.

$0.27 looks like a good entry point. Not expensive as PE is only 12.

http://mystocksinvesting.blogspot.com/2010/05/china-animal-health-nice-waves-on-up.html

 

 

 

Someone gonna force u to sell to them at 0.1x soon.

risktaker      ( Date: 25-Apr-2010 20:43) Posted: I will only buy this @ 0.25 - 0.27 range

 

I will only buy this @ 0.25 - 0.27 range

 

Your trading principle is sound but bad for the heart. I generally prefer to buy in 1st entry (28c) 100 lots, 2nd entry (28c) 100 lots and 3rd and last entry (15c) 200 lots. Learnt this 3-entry technique from someone on this forum last year and refined it from listening to Cramer on CNBC. Cheers.

kenkenken      ( Date: 23-Apr-2010 22:40) Posted: at 28c u buy $28,000, 25c u whack another $50000, 15c u whack another 45,000 but the problem is at 25c u will see alot of red in your account. u dare anot

 

 

What to do?? Or else just hold and hold lor.... No choice........

kenkenken      ( Date: 23-Apr-2010 22:40) Posted: at 28c u buy $28,000, 25c u whack another $50000, 15c u whack another 45,000 but the problem is at 25c u will see alot of red in your account. u dare anot

 

at 28c u buy $28,000, 25c u whack another $50000, 15c u whack another 45,000 but the problem is at 25c u will see alot of red in your account. u dare anot

 

I bought at 34.5c.......... Who can force me to sell leh........... At 28c, I whack another 100L avg down......... If 25c I whack 200L........... If reaches 15c, 300L...........

 

I won't be the one sell to u......

risktaker      ( Date: 22-Apr-2010 19:23) Posted: I will buy @ 0.25-0.27 range :) Good luck to those who get stuck at 0.33-0.36 :P Someone gonna force u to sell to them at 0.2x soon. hp3000      ( Date: 22-Apr-2010 17:50) Posted: CHINA Animal Healthcare could start paying dividends as early as mid-year if its expansion plans bear fruit. The company - which has not paid a cent since it was listed in 2007 - hinted at this during its annual general meeting (AGM) yesterday when asked why it was not making payouts despite strong profits, a significant cash hoard and a solid balance sheet with virtually zero debt. 'We are currently in an aggressive acquisitive expansion phase,' said chairman and founder Wang Yangang, who flew into Singapore for the meeting. 'We have just acquired the capacity to scale up into high value-added biological vaccines. While this is happening, we want to conserve some cash for working capital needs.' According to him, that faster-than-expected introduction of the new vaccines - used mostly on pigs against hand, foot and mouth disease, as well as the swine fever - could yield returns this year which the company could distribute to shareholders. 'Things have been moving fairly rapidly and we are happy with the progress,' he said, referring to supply contracts clinched with regional municipal veterinary agencies across China. China Animal is one of only five animal vaccine producers in China - and the only private sector player. Regulations stipulate that all farmers in China must use these drugs on bred pigs. The company's four competitors are state-run agencies which use older-generation drugs. China Animal has made two major acquisitions in the past year, the latest of which was its 210 million yuan (S $42.3 million) purchase in January of Jianxiang Hemu Biological Technology, which produces a vaccine against the porcine reproductive and respiratory syndrome. For the year ended Dec 31, 2009, China Animal lifted full-year profit 14.2 per cent to 157.9 million yuan on a 13.8 per cent rise in revenue to 438.3 million yuan. It said it had about 200 million yuan in its kitty as at end-March. Mr Wang and his directors were also yesterday asked about plans for a dual listing in Hong Kong. Speaking to BT later, he said work on a dual listing began in December and the process is well advanced. He said the listing could be completed in six months, if all goes well. Asked why China Animal was seeking a second listing, he said: 'The Hong Kong market knows us better and will offer us a better valuation.' China Animal has no peers here for comparison. But Mr Wang said that compared with its 14 times price-earnings (PE) multiple here, Shanghai-listed companies such as China Animal Husbandry Industry, Xinjiang Tiankang Animal Science Bio-Technology and Inner Mongolia Jinyu Group are commanding PEs of 40-50 times.

 

I will buy @ 0.25-0.27 range :) Good luck to those who get stuck at 0.33-0.36 :P

Someone gonna force u to sell to them at 0.2x soon.

hp3000      ( Date: 22-Apr-2010 17:50) Posted: CHINA Animal Healthcare could start paying dividends as early as mid-year if its expansion plans bear fruit. The company - which has not paid a cent since it was listed in 2007 - hinted at this during its annual general meeting (AGM) yesterday when asked why it was not making payouts despite strong profits, a significant cash hoard and a solid balance sheet with virtually zero debt. 'We are currently in an aggressive acquisitive expansion phase,' said chairman and founder Wang Yangang, who flew into Singapore for the meeting. 'We have just acquired the capacity to scale up into high value-added biological vaccines. While this is happening, we want to conserve some cash for working capital needs.' According to him, that faster-than-expected introduction of the new vaccines - used mostly on pigs against hand, foot and mouth disease, as well as the swine fever - could yield returns this year which the company could distribute to shareholders. 'Things have been moving fairly rapidly and we are happy with the progress,' he said, referring to supply contracts clinched with regional municipal veterinary agencies across China. China Animal is one of only five animal vaccine producers in China - and the only private sector player. Regulations stipulate that all farmers in China must use these drugs on bred pigs. The company's four competitors are state-run agencies which use older-generation drugs. China Animal has made two major acquisitions in the past year, the latest of which was its 210 million yuan (S $42.3 million) purchase in January of Jianxiang Hemu Biological Technology, which produces a vaccine against the porcine reproductive and respiratory syndrome. For the year ended Dec 31, 2009, China Animal lifted full-year profit 14.2 per cent to 157.9 million yuan on a 13.8 per cent rise in revenue to 438.3 million yuan. It said it had about 200 million yuan in its kitty as at end-March. Mr Wang and his directors were also yesterday asked about plans for a dual listing in Hong Kong. Speaking to BT later, he said work on a dual listing began in December and the process is well advanced. He said the listing could be completed in six months, if all goes well. Asked why China Animal was seeking a second listing, he said: 'The Hong Kong market knows us better and will offer us a better valuation.' China Animal has no peers here for comparison. But Mr Wang said that compared with its 14 times price-earnings (PE) multiple here, Shanghai-listed companies such as China Animal Husbandry Industry, Xinjiang Tiankang Animal Science Bio-Technology and Inner Mongolia Jinyu Group are commanding PEs of 40-50 times.

 

CHINA Animal Healthcare could start paying dividends as early as mid-year if its expansion plans bear fruit.

The company - which has not paid a cent since it was listed in 2007 - hinted at this during its annual general meeting (AGM) yesterday when asked why it was not making payouts despite strong profits, a significant cash hoard and a solid balance sheet with virtually zero debt.

'We are currently in an aggressive acquisitive expansion phase,' said chairman and founder Wang Yangang, who flew into Singapore for the meeting. 'We have just acquired the capacity to scale up into high value-added biological vaccines. While this is happening, we want to conserve some cash for working capital needs.'

According to him, that faster-than-expected introduction of the new vaccines - used mostly on pigs against hand, foot and mouth disease, as well as the swine fever - could yield returns this year which the company could distribute to shareholders.

'Things have been moving fairly rapidly and we are happy with the progress,' he said, referring to supply contracts clinched with regional municipal veterinary agencies across China.

China Animal is one of only five animal vaccine producers in China - and the only private sector player. Regulations stipulate that all farmers in China must use these drugs on bred pigs.

The company's four competitors are state-run agencies which use older-generation drugs.

China Animal has made two major acquisitions in the past year, the latest of which was its 210 million yuan (S $42.3 million) purchase in January of Jianxiang Hemu Biological Technology, which produces a vaccine against the porcine reproductive and respiratory syndrome.

For the year ended Dec 31, 2009, China Animal lifted full-year profit 14.2 per cent to 157.9 million yuan on a 13.8 per cent rise in revenue to 438.3 million yuan. It said it had about 200 million yuan in its kitty as at end-March.

Mr Wang and his directors were also yesterday asked about plans for a dual listing in Hong Kong.

Speaking to BT later, he said work on a dual listing began in December and the process is well advanced. He said the listing could be completed in six months, if all goes well.

Asked why China Animal was seeking a second listing, he said: 'The Hong Kong market knows us better and will offer us a better valuation.'

China Animal has no peers here for comparison. But Mr Wang said that compared with its 14 times price-earnings (PE) multiple here, Shanghai-listed companies such as China Animal Husbandry Industry, Xinjiang Tiankang Animal Science Bio-Technology and Inner Mongolia Jinyu Group are commanding PEs of 40-50 times.

 

seens to be sinking

 

wah lau ah !! PD PD PD siazzzzzz !!!

 

what is the tp for this ctr tks.

 

stock dual listing in hk soon

 

if the stock goes back down to $0.26 have to worry

 

Now your luck has come!!! Today closed at 30cents. The price didnt move this morning, untill the late afternoon then went up a cent. I think  Next week should be another cheong week.

Hulumas      ( Date: 25-Mar-2010 12:45) Posted: Me too, I hold this share for long term. focusy      ( Date: 25-Mar-2010 05:41) Posted: Last month, Kevin Scully advised investors to buy at 24 cents, saying: " The recent weakness in the share price from its high of about 30 cents provides good buying opportunity for investors who missed out earlier." He likes the prospects of China Animal Healthcare. U read http://www.nextinsight.net/content/view/2092/79/

 

Me too, I hold this share for long term.

focusy      ( Date: 25-Mar-2010 05:41) Posted: Last month, Kevin Scully advised investors to buy at 24 cents, saying: " The recent weakness in the share price from its high of about 30 cents provides good buying opportunity for investors who missed out earlier." He likes the prospects of China Animal Healthcare. U read http://www.nextinsight.net/content/view/2092/79/

 

Last month, Kevin Scully advised investors to buy at 24 cents, saying: " The recent weakness in the share price from its high of about 30 cents provides good buying opportunity for investors who missed out earlier."

He likes the prospects of China Animal Healthcare. U read http://www.nextinsight.net/content/view/2092/79/

 

You're right ... this ctr ran today closed at 29.5cents with more buying at this price ... must be some good news soon ...

 

 

I've just bought in 50lots at 27cents. This countelr can develop further. I'm waiting this counter to fly sooner this year.

 

Strong buy in for ChinaAniH @ $0.27